T. Wessendorf (Essen, Germany), P. Faverio (Limbiate (MI), Italy), P. Molyneaux (London, United Kingdom), E. Börner (Erkrath, Germany)
Autoimmune pulmonary alveolar proteinosis complicated with sarcoidosis: clinical courses and serum levels of anti-GM-CSF autoantibody
T. Arai (Sakai, Japan), T. Kasai (Sakai, Japan), A. Matsumuro (Sakai, Japan), C. Sugimoto (Sakai, Japan), M. Hirose (Sakai, Japan), N. Takeuchi (Sakai, Japan), K. Katayama (Sakai, Japan), M. Akira (Sakai, Japan), M. Kitaichi (Tanabe, Japan), Y. Inoue (Sakai, Japan)
|  |
Neutralizing capacity of autoantibody against GM-CSF in patients with autoimmune pulmonary alveolar proteinosis
E. Yamaguchi (Nagakute, Japan), K. Kosaka (Nagakute, Japan), T. Yonezawa (Nagakute, Japan), H. Shibata (Nagakute, Japan), A. Matsubara (Nagakute, Japan), T. Kato (Nagakute, Japan), H. Tanaka (Nagakute, Japan), N. Yokoe (Nagakute, Japan), S. Ito (Nagakute, Japan), A. Kubo (Nagakute, Japan)
|  |
Our cases with pulmonary alveolar proteinosis
G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), G. Öcal (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey)
| |
Lung cysts in pulmonary alveolar proteinosis.
M. Kokosi (London, United Kingdom), P. Saunders (London, United Kingdom), P. Molyneaux (London, United Kingdom), P. George (London, United Kingdom), G. Margaritopoulos (London, United Kingdom), V. Kouranos (London, United Kingdom), T. Pickworth (London, United Kingdom), F. Chua (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom), C. Morgan (London, United Kingdom)
| |
Lung disease caused by non-null ABCA3 mutations: long-term follow-up
E. Manali (Athens, Greece), N. Nathan (Paris, France), C. Kannengiesser (Paris, France), P. Tomos (Athens, Greece), A. Coulomb-L’Hermine (Paris, France), P. Korkolopoulou (Athens, Greece), P. Foukas (Athens, Greece), L. Kolilekas (Athens, Greece), K. Kagouridis (Athens, Greece), M. Maniati (Athens, Greece), S. Argentos (Athens, Greece), I. Korbila (Athens, Greece), I. Tomos (Athens, Greece), N. Roussakis (Athens, Greece), M. Kallieri (Athens, Greece), A. Schams (Munich, Germany), M. Griese (Munich, Germany), T. Tsiligiannis (Athens, Greece), A. Karakatsani (Athens, Greece), S. Loukides (Athens, Greece), G. Koutsocheras (Athens, Greece), A. Androu (Athens, Greece), M. Legendre (Paris, France), S. Amselem (Paris, France), R. Borie (Paris, France), B. Crestani (Paris, France), S. Papiris (Athens, Greece)
| |
Lung involvement associated with anti-NXP2 autoantibodies: a monocentre observational French study
J. Bermudez (Marseille, France), B. Coulon (Marseille, France), Y. Trigui (Marseille, France), C. Gomez (Marseille, France), J. Mege (Marseille, France), N. Bardin (Marseille, France), M. Reynaud-Gaubert (Marseille, France)
| |
Genetic interstitial lung disease: an unusual case
M. Gros (Creteil, France), A. De Becdelièvre (Creteil, France), D. Lehalle (Creteil, France), C. Delestrain (Creteil, France), A. Le Floch (Creteil, France), B. Funalot (Creteil, France), P. Fanen (Creteil, France), R. Epaud (Creteil, France)
| |
Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis
G. Dabar (Beirut, Lebanon), Z. Aoun (Beirut, Lebanon), M. Riachi (Beirut, Lebanon), J. Boutros (Beirut, Lebanon), G. Khayat (Beirut, Lebanon)
| |
Acute eosinophilic pneumonia due to heroin inhalation
C. Dogan (Isparta, Turkey), H. Bircan (Isparta, Turkey)
| |
Relapse predictive factors of chronic eosinophilic pneumonia
N. Takeuchi (Sakai, Japan), T. Arai (Sakai, Japan), Y. Sasaki (Sakai, Japan), Y. Matsuda (Sakai, Japan), K. Katayama (Sakai, Japan), C. Sugimoto (Sakai, Japan), K. Tachibana (Sakai, Japan), S. Hayashi (Sakai, Japan), M. Akira (Sakai, Japan), T. Kasai (Sakai, Japan), M. Kitaichi (Tanabe, Japan), Y. Inoue (Sakai, Japan)
| |
Eosinophilic Pneumonia Due to Sulphasalazine Use
S. Sökücü (Istanbul, Turkey), C. öZdemir (Istanbul, Turkey), ö. Kahya (Istanbul, Turkey), S. Tural öNüR (Istanbul, Turkey)
| |
Pulmonary toxicity to mesalazine
M. Araújo Pereira (Braga, Portugal), M. Araújo (Braga, Portugal), F. Lemos Aguiar (Braga, Portugal), J. Vale Lages (Braga, Portugal), A. Vieira (Braga, Portugal), J. Cruz (Braga, Portugal)
| |
Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF)
C. Sköld (Stockholm, Sweden), K. Bartley (South San Francisco, United States of America), A. Levine (Solna, Sweden), L. Arnheim-Dahlstrom (Solna, Sweden), K. Kirchgaessler (Basel, Switzerland), R. Linder (Solna, Sweden), C. Janson (Uppsala, Sweden), G. Ferrara (Stockholm, Sweden)
| |
Transbronchial cryobiopsy in interstitial lung disease
L. Hagmeyer (Solingen, Germany), D. Theegarten (Essen, Germany), M. Treml (Solingen, Germany), A. Pietzke-Calcagnile (Solingen, Germany), S. Herkenrath (Solingen, Germany), W. Randerath (Solingen, Germany)
| |
Prevalence of progressive fibrosing interstitial lung disease
A. Olson (Denver, Colorado, United States of America), N. Hartmann (Ingelheim am Rhein, Germany), R. Schlenker-Herceg (Ingelheim am Rhein, Germany), L. Wallace (Ridgefield, Connecticut, United States of America)
| |
Smoking-related intersticial fibrosis (srif): A new entity?
E. De Freitas Gonzalez (León, Spain), J. Villegas Alcázar (León, Spain), R. Almeida Cabrera (León, Spain), C. Mier Bango (León, Spain), L. Sierra Herranz (León, Spain), J. Juan García (León, Spain), I. Herráez Ortega (León, Spain), N. Alonso Orcajo (León, Spain), S. García García (León, Spain), E. Bollo De Miguel (León, Spain)
| |
Atypical presentation of a rare lung condition: axillary and paraspinal lymphadenopathy in a patient with clinical and radiological features of lymphangioleomatosis (LAM )
A. Kavidasan (London, United Kingdom), V. Taylor (London, United Kingdom), S. Chaudhry (London, United Kingdom), R. Siva (London, United Kingdom), Y. Raste (London, United Kingdom)
| |
Case of lymphangioleiomyomatosis complicated by severe alveolar hemorrhagic syndrome
O. Fesenko (Moscow, Russian Federation), S. Shwaiko (Moscow, Russian Federation), Z. Sheykh (Moscow, Russian Federation), O. Paklina (Moscow, Russian Federation), E. Kulaeva (Moscow, Russian Federation)
| |
False-positive PET-CT scan secondary to interstitial pneumonitis mimicking malignancy in fire eater’s lung
A. Baccioglu (Kirikkale, Turkey), D. Eraslan (Kirikkale, Turkey), S. Halici (Kirikkale, Turkey), F. Kalpaklioglu (Kirikkale, Turkey)
| |
The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis (GPA) in own material.
J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland), V. Petroniec (Warsaw, Poland), E. Augustynowicz-Kopec (Warsaw, Poland), M. Bednarek (Warsaw, Poland), D. Gawryluk (Warsaw, Poland), M. Martusewicz-Boros (Warsaw, Poland), K. Modrzewska (Warsaw, Poland), E. Radzikowska (Warsaw, Poland), K. Roszkowski-Sliz (Warsaw, Poland)
| |